Patent ID: 9675660
Date: 2017-06-13
CPC Classifications: A61B,A61F,A61K,A61P

Claim:
1. A method of inhibiting angiogenesis comprising administering to a patient in need thereof an isolated peptide comprising the amino acid sequence of KFARLWTEIPTAIT (SEQ ID NO: 1) or FTEIPTI (SEQ ID NO: 3), wherein the patient is suffering from cancer, visual impairment, vision loss (blindness), macular degeneration, central retinal vein occlusion, branch retinal vein occlusion proliferative diabetic retinopathy, neovascular age-related macular degeneration (AMD), retinopathy of prematurity, ischemic retinopathy, intraocular neovascularization, corneal neovascularization, retinal neovascularization, choroidal neovascularization, diabetic macular edema, diabetic retina ischemia, diabetic retinal edema, and proliferative diabetic retinopathy, rubeosis iridis, neovascular glaucoma, retinoblastoma, uveitis or corneal graft neovascularization.